Package 71335-1394-1

{"route": ["ORAL"], "spl_id": "3af9a0f0-8a7f-4735-85ae-a3427e2f951d", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897649"], "spl_set_id": ["2f839b5c-b8e7-40df-887f-7df94326fc7b"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-1394-1)", "package_ndc": "71335-1394-1", "marketing_start_date": "20220209"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-1394-2)", "package_ndc": "71335-1394-2", "marketing_start_date": "20220209"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-1394-3)", "package_ndc": "71335-1394-3", "marketing_start_date": "20220209"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (71335-1394-5)", "package_ndc": "71335-1394-5", "marketing_start_date": "20220209"}], "brand_name": "VERAPAMIL HYDROCHLORIDE", "product_id": "71335-1394_3af9a0f0-8a7f-4735-85ae-a3427e2f951d", "dosage_form": "TABLET", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71335-1394", "generic_name": "VERAPAMIL HYDROCHLORIDE", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VERAPAMIL HYDROCHLORIDE", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA206173", "marketing_category": "ANDA", "marketing_start_date": "20190515", "listing_expiration_date": "20261231"}